- Home
- / Elevation Oncology
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Elevation Oncology financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.6
2024-10-29
Market Capitalization
$35.1 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 |
|---|---|---|---|---|
| General and administrative expense | 8.5M | 15.8M | 14.9M | 16.1M |
| Operating expense total | 94.5M | 44.7M | ||
| EBIT | (32.0M) | (94.5M) | (45.4M) | (44.7M) |
| Interest expense | 4.2M | 4.0M | ||
| Pre tax profit | (95.1M) | (45.7M) | (44.4M) | |
| Income tax expense | 25.0K | 30.0K | 43.0K | |
| Net Income | (32.0M) | (95.1M) | (45.7M) | (44.5M) |
| EPS | (4.1) | (1.0) | (0.8) |